# An Unusual Presentation of Synchronous Breast Cancer and Skin Malignancy in a Patient with Lynch Syndrome: A Case Report and Review of the Literature

**Authors:** Maiar Elghobashy, Michael Siafakas, Mona Elshafie, Rahul Hejmadi, Naren N. Basu, Abeer M. Shaaban

PMC · DOI: 10.3390/biomedicines12061242 · 2024-06-03

## TL;DR

A 54-year-old woman with Lynch syndrome developed breast cancer and a skin malignancy simultaneously, highlighting the varied cancer risks in this condition.

## Contribution

This case report adds to the evidence of diverse malignancies associated with Lynch syndrome, including synchronous breast and skin cancers.

## Key findings

- The patient had a MLH1 gene mutation and presented with triple-negative breast cancer and a skin lesion with sebaceous differentiation.
- Both lesions showed MSH1 and PMS2 deficiency, consistent with Lynch syndrome.
- The case emphasizes the need for vigilance in monitoring multiple cancer types in Lynch syndrome patients.

## Abstract

Background: Lynch syndrome is an autosomal dominant condition that leads to an increased risk of many neoplasms. In the United Kingdom, NICE recommends that patients with colorectal and endometrial cancer should be tested for Lynch syndrome. There is conflicting evidence in the literature on the link between breast cancer and Lynch syndrome. Case presentation: A 54-year-old woman presented with a lump in her right breast with a background of locally advanced colorectal cancer and Lynch syndrome due to a MLH1 gene mutation. A core biopsy showed a grade 3, invasive, triple-negative NST carcinoma. The tumour was triple-negative with patchy positivity for CK14 and CK5/6. Simultaneously, a cystic skin lesion in the contralateral breast was noted, which comprised lesional cells with a proliferation of clear cells and bland basaloid cells. The lesion had evidence of sebaceous differentiation with AR, podoplanin and p63 positivity. MSH1 and PMS2 deficiency was found in the breast and skin lesions. Conclusions: In Lynch syndrome, it is vital to be aware of the increased risk of various types of cancer. This case adds to the body of evidence of the spectrum of malignancies that can be encountered in patients with Lynch syndrome.

## Linked entities

- **Genes:** MLH1 (mutL homolog 1) [NCBI Gene 4292], MSH1 (DNA mismatch repair protein) [NCBI Gene 732638], PMS2 (PMS1 homolog 2, mismatch repair system component) [NCBI Gene 5395], KRT14 (keratin 14) [NCBI Gene 3861], ck56 (hypothetical protein) [NCBI Gene 310612231], AR (androgen receptor) [NCBI Gene 367]
- **Diseases:** Lynch syndrome (MONDO:0005835), colorectal cancer (MONDO:0005575), endometrial cancer (MONDO:0002447), breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** MLH1 (mutL homolog 1) [NCBI Gene 4292] {aka COCA2, FCC2, HNPCC, HNPCC2, LYNCH2, MLH-1}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, PDPN (podoplanin) [NCBI Gene 10630] {aka AGGRUS, D2-40, GP36, GP40, Gp38, HT1A-1}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}
- **Diseases:** Skin Malignancy (MESH:D009369), skin lesion (MESH:D012871), Breast Cancer (MESH:D001943), PMS2 deficiency (MESH:D007153), lump (MESH:C536531), Lynch Syndrome (MESH:D003123), colorectal cancer (MESH:D015179), colorectal and endometrial cancer (MESH:D016889), autosomal dominant condition (MESH:C566739)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11201021/full.md

---
Source: https://tomesphere.com/paper/PMC11201021